| |
Mol Cell, Vol. 7, No. 2. (February 2001), pp. 249-262.
|
| |
|
| |
Nature Genetics, Vol. 39, No. 2. (31 December 2006), pp. 159-161.
by Bing Xia, Josephine C. Dorsman, Najim Ameziane, et al.Yne de Vries, Martin A. Rooimans, Qing Sheng, Gerard Pals, Abdellatif Errami, Eliane Gluckman, Julian Llera, Weidong Wang, David M. Livingston, Hans Joenje, Johan P. de Winter
|
| |
Cancer research, Vol. 59, No. 7 Suppl. (1 April 1999)
|
| |
Mol. Cell. Biol., Vol. 25, No. 5. (1 March 2005), pp. 1949-1957.
|
| |
Baillière's best practice & research. Clinical haematology, Vol. 13, No. 3. (September 2000), pp. 407-425.
|
| |
Nat Rev Genet, Vol. 2, No. 6. (June 2001), pp. 446-457.
|
| |
Human molecular genetics, Vol. 10, No. 20. (1 October 2001), pp. 2253-2259.
|
| |
Nature Reviews Genetics, Vol. 8, No. 10. (04 September 2007), pp. 735-748.
|
| |
BMC biochemistry, Vol. 8 Suppl 1 (2007)
|
| |
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, Vol. 10, No. 2. (February 2008), pp. 78-84.
|
| |
Anti-cancer agents in medicinal chemistry, Vol. 8, No. 4. (May 2008), pp. 426-430.
|
| |
Nat Rev Cancer, Vol. 3, No. 1. (January 2003), pp. 23-34.
|
| |
British journal of cancer, Vol. 98, No. 8. (22 April 2008), pp. 1452-1456.
|
| |
Cancer biology & therapy, Vol. 5, No. 3. (March 2006), pp. 256-260.
|
| |
Molecular cancer therapeutics, Vol. 5, No. 4. (April 2006), pp. 952-961.
by D. Chirnomas, T. Taniguchi, M. de la Vega, et al.A. P. Vaidya, M. Vasserman, A. R. Hartman, R. Kennedy, R. Foster, J. Mahoney, M. V. Seiden, A. D. D'Andrea
|
| |
Molecular cancer therapeutics, Vol. 5, No. 12. (December 2006), pp. 3153-3161.
|
| |
BMC Cancer, Vol. 7 (06 August 2007), 152.
|
| |
Cancer cell, Vol. 3, No. 5. (May 2003), pp. 417-420.
|
| |
Cell cycle (Georgetown, Tex.), Vol. 2, No. 4. (g 2003), pp. 290-292.
|
Search
